YIYuki Inoue

Yuki Inoue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuki Inoue has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone-induced toxicities in rats: comparative study with other mitochondrial uncouplers (2,4-dinitrophenol, OPC-163493 and tolcapone)

    by Yuki Inoue, Yuko Wada, Makoto Sato, Seiji Sato, Takashi Okamoto, Naohide Kanemoto

    FCCP (carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone) is known to inhibit oxidative phosphorylation as a protonophore, dissipating the proton gradient across the inner mitochondrial membrane. To understand the toxicity of FCCP, 3-day, 2- and 4-week repeated oral dose studies were performed in male rats. In the 3-day and 2-week repeated dose toxicity studies, observations included salivation, increased body temperature, and dead and moribund animals. Increased liver weight was observed in conjunction with hydropic degeneration and centrilobular necrosis of hepatocytes. In addition, pathological changes were observed in the pancreas, testis, epididymal duct, stomach and parotid gland. Electron microscopic examination revealed mitochondrial pleomorphism in the hepatocytes. Swelling of mitochondria was observed in the alpha cells and beta cells of the pancreas. Dilatation of rough endoplasmic reticulum, Golgi bodies and loss of secretory granules were also noted in the beta cells of the pancreas. FCCP was also compared with three other mUncouplers (DNP, OPC-163493 and tolcapone) with regard to in vitro mitochondrial uncoupling (mUncoupling) activities. FCCP produced the peak ΔOCR (oxygen consumption rate) at the lowest concentration (0.4 μM), followed by OPC-163493, tolcapone, and DNP, based on peak values in ascending order of concentration (2.5, 10, and 50 μM, respectively). Considering the relationship between the mUncoupling activity and toxicity profile of the four mUncouplers, there is no parallel relationship between the in vitro mUncoupling activity and the degree of in vivo toxicity. These findings may contribute to the efficient development of new mitochondrial uncoupler candidates.


  • Open Access

    Preclinical safety profile of a liver-localized mitochondrial uncoupler

    by Yuki Inoue, Junichi Kino, Nobuya Ishiharada, Makoto Sato, Suguru Hatanaka, Hiroyuki Yokoi, Takahiro Shimada, Seiji Sato, Takashi Okamoto, Naohide Kanemoto

    Mitochondrial uncouplers (mUncouplers) are known to exhibit a variety of toxic effects in animals. Here we report a safety profile of an mUncoupler, OPC-163493, recently synthesized at Otsuka Pharmaceutical Co, Ltd, and its development as a therapeutic agent for treating diabetes. To understand the acute and subchronic toxicity of OPC-163493, single and repeated oral dose studies in rats, dogs, and monkeys were performed. In the rat studies, rigor mortis and increased body temperatures were observed in the high dose group. Focal necrosis, fatty change, and granular eosinophilic cytoplasm of the hepatocytes were also observed in the high dose group. In the dog studies, gastrointestinal manifestations were observed with decreased body weight and decreased food consumption in the high dose group. Necrotizing arteritis was observed in multiple organs as well as meningitis with hemorrhage in the brain. In the monkey studies, vomiting, decreased food consumption, and decreased locomotor activity were observed in the high dose group. Degeneration of the proximal convoluted tubules and the straight tubular epithelium, regeneration of the proximal tubular epithelium, and degeneration of the collecting tubular epithelium were observed. The target organs of OPC-163493 were liver, blood vessels, and kidney in rats, dogs, and monkeys, respectively. In rats, dogs, and monkeys, safety ratios were 100:1, 13:1, and 20:1, respectively, in terms of total exposure (AUC24h). These safety ratios showed clear separation between exposure to OPC-163493 in animals at NOAEL and the exposure at the effective dose in ZDF rats. This information should contribute to the drug development of new and effective mUncoupler candidates.


  • Open Access

    Excess adiponectin in eyes with progressive ocular vascular diseases

    by Anri Nishinaka, Shinsuke Nakamura, Miruto Tanaka, Tomomi Masuda, Yuki Inoue, Takumi Yamamoto, Takahiko Imai, Yae Hidaka, Masamitsu Shimazawa, Hideaki Hara

    Anti‐vascular endothelial growth factor (VEGF) therapies are now the first‐line treatment for many ocular diseases, but some patients are non‐responders to these therapies. The purpose of this study was to determine whether the level of adiponectin increased the pathogenesis of retinal edema and neovascularization in the retina of progressive ocular vascular diseases. We examined the role played by adiponectin in two types of cells and animal models which are retinal vein occlusion (RVO) and oxygen‐induced retinopathy (OIR) mice. Our results showed that an injection of anti‐adiponectin antibody ameliorated the retinal edema and ischemia through the depression of the expression level of VEGF‐related factors and tight junction‐related proteins in the retina of RVO mice. The intravitreal injection of anti‐adiponectin antibody also decreased the degree of retinal neovascularization in an OIR mice. In addition, exposure of human retinal microvascular endothelial cells and human brain microvascular pericytes in culture to adiponectin increased both the vascular permeability and neovascularization through the increase of inflammatory factor and the dropout of the pericytes. These findings indicate that adiponectin plays a critical role in retinal edema and neovascularization, and adiponectin is a potential therapeutic target for the treatment of diabetic macular edema, proliferative diabetic retinopathy, and RVO.


  • Involvement of cannabinoid receptor type 2 in light-induced degeneration of cells from mouse retinal cell line in vitro and mouse photoreceptors in vivo

    by Tomoyo Imamura, Kazuhiro Tsuruma, Yuki Inoue, Tomohiro Otsuka, Yuta Ohno, Shiho Ogami, Shinsaku Yamane, Masamitsu Shimazawa, Hideaki Hara


  • DOA error estimation using 2.6 GHz DBF array antenna

    by Y. Inoue, K. Mori, H. Arai

    The DOA (Direction Of Arrival angle) estimation errors due to hardware problems are investigated experimentally using a four-channel DBF array antenna system operating at the 2.6 GHz IMS band. The DOA estimation by the MUSIC (MUltiple SIgnal Classification) algorithm is examined inside a radio anechoic chamber to clarify the estimation error mechanism. The purpose of this paper is to estimate the DOA correctly for all arrival directions. To examine the error in detail, the estimation error has been measured in the case of one transmission source, and the error is /spl plusmn/12 degrees without any corrections. We investigated these error factors and found two major factors: the inaccurate interval of array elements and the mutual coupling between the elements. By compensating these errors using the mode vector measured correctly, the error was reduced to /spl plusmn/3 degrees. In addition, when the mode vector, measured at intervals of up to 20 degrees, is interpolated by the spline interpolation method, the estimation error is restrained within /spl plusmn/5 degrees.


  • Open Access

    A New Method for Counting of Quail Leukocytes by Flow Cytometry.

    by Tadaaki Moritomo, Ai Minami, Yuki Inoue, Teruyuki Nakanishi

    An automatic counting method was developed for fish blood cells using a fluorescent dye, 3, 3-dihexyloxacarbocyanine (DiOC 6(3)), that selectively stain lipid bilayers in living cells. In the present study, the DiOC6(3) method was applied to quail (Cotumix cotumix japonica) blood cells. After quail blood cells were stained with DiOC6(3), absolute counts and relative proportions of erythrocytes, granulocytes, monocytes, and lymphocytes plus thrombocytes in whole blood were obtained by means of flow cytometry (FC). The number of each cell types by the FC was in good agreement with those counted microscopically. This method will offer new possibilities for routine blood cell counting for avian medicine.